🇺🇸 FDA
Patent

US 11767330

Citrate salt, pharmaceutical compositions, and methods of making and using the same

granted A61KA61K31/4545

Quick answer

US patent 11767330 (Citrate salt, pharmaceutical compositions, and methods of making and using the same) held by FOGHORN THERAPEUTICS INC. expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
FOGHORN THERAPEUTICS INC.
Grant date
Tue Sep 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/4545